Accuray's Fiscal 2026 Third Quarter Financial Results Show Mixed Growth and Strategic Advancements

Accuray Reports Fiscal 2026 Third Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) recently released its financial results for the third quarter, which ended on March 31, 2026. The results shed light on the company's ongoing transformation plan and other critical developments affecting its performance.

Key Highlights

1. Transformation Plan Impact: Accuray has notably achieved approximately $10 million in cost reductions and margin improvements, positioning it ahead of the initial $12 million target for FY26. The transformation plan, which of course was initiated back in December, is now showing positive results, exceeding company expectations.

2. New Leadership: In a strategic move to bolster its commercial endeavors, Accuray appointed Paul Miele as Chief Commercial Officer. With extensive experience in scaling capital medical device businesses, Miele is expected to expedite the growth trajectory of the company.

3. Strategic Partnerships: The company is reinforcing its ecosystem by forging strategic partnerships across imaging, software, workflow, clinical research, and operational execution, amplifying Accuray's competitive edge in the market.

4. Geopolitical Challenges: Ongoing geopolitical uncertainties, particularly in the Middle East, have compelled Accuray to withdraw its financial projections for FY26. The disruptions have impacted product shipments and service revenues, causing delays in installations in several affected markets.

5. Upcoming Congress Appearance: Accuray will present at the European Society for Radiotherapy and Oncology (ESTRO) Congress from May 15-19, 2026, in Stockholm, Sweden. The company plans to showcase various customer-driven product enhancements aimed at upholding its standards of clinical excellence and innovation.

Financial Overview

During fiscal Q3 2026, Accuray reported total net revenues of $104.8 million, signifying a 7% decline compared to $113.2 million from the same quarter in the previous year. Product revenue dropped 13% to $49.7 million, while service revenue experienced a modest decrease of 1% to $55.1 million, compared to the same period last year.

Total gross profit reached $25.3 million, constituting 24.1% of the total net revenue, down from $31.6 million (27.9%) in the prior year’s quarter. This drop in gross margin was primarily attributed to elevated costs related to parts and logistics.

Accuray's operating expenses rose to $34.4 million, marking a 12% increase compared to $30.6 million in the same quarter the previous year. This figure includes $6.5 million in restructuring charges. When these restructuring costs are excluded, operating expenses actually saw a decrease of 9%, owing to a prior year bonus reversal of $3.2 million.

The company reported a net loss of $11.8 million for the quarter, a significant increase compared to the $1.3 million loss year-over-year, translating to a diluted net loss of $0.09 per share.

Order Activity

Gross product orders in Q3 were valued at $48.5 million, a stark contrast to $71.2 million from the same quarter last year, resulting in a book-to-bill ratio of 1.0 compared to 1.2 previously.

As of March 31, 2026, the order backlog stood at $356.2 million, representing a 21% decrease from the previous year.

Cash Position

Accuray's liquidity position slightly weakened, as total cash and cash equivalents fell from $62.1 million in June 2025 to $44.4 million by the end of March 2026.

First Nine Months Results

For the first nine months of fiscal 2026, total net revenue is reported at $301 million, a 9% decrease year-over-year. Notably, product revenue dropped by 21%. Adjusted EBITDA for this period registered negatively at $2.3 million, sharply contrasting the $18.8 million in the prior fiscal year.

Despite the challenges faced in this fiscal period, Accuray remains ambitious about future growth and profitability, particularly as it navigates market uncertainties and focuses on operational improvements.

Conclusion

Accuray’s recent strategic moves, including leadership appointments and partnerships, coupled with critical transformations, highlight its commitment to overcoming current challenges. Nevertheless, the company is exercising caution in its financial outlook as it awaits better market conditions and improved operational performance.